Hydrastinine hydrochloride (Legacy Tebubio ref. 282T1607). Hydrastinine hydrochloride is a semisynthetic alkaloid from the hydrolysis of the alkaloid Hydrastine, used as a haemostatic drug.
Sizes: 1 mg, 5 mg, 25 mg, 100 mg, 50 mg, 10 mg, 200 mg, 1 mL * 10 mM (in DMSO)
From: €40.00
MF63 (Legacy Tebubio ref. 282T16070). MF63 is a selective mPGES-1 inhibitor (IC50: 0.9 nM and 1.3 nM for pig mPGES-1 and human mPGES-1 enzyme, respectively).
Sizes: 1 mg, 5 mg, 25 mg, 100 mg, 50 mg, 10 mg, 1 mL * 10 mM (in DMSO)
From: €50.00
Mifobate (Legacy Tebubio ref. 282T16074). Mifobate (SR-202) is a potent and specific antagonist of PPARγ, exhibiting antiobesity, antidiabetic, and antiatherosclerotic effects[1].
Sizes: 1 mg, 5 mg, 25 mg, 50 mg, 10 mg, 1 mL * 10 mM (in DMSO)
From: €60.00
(Rac)-Idroxioleic acid (Legacy Tebubio ref. 282T16075). (Rac)-Idroxioleic acid (2-Hydroxyoleic acid) is a fatty acid amide hydrolase inhibitor with anti-tumor properties that binds to the plasma membrane, altering lipid organization.
Mioflazine (Legacy Tebubio ref. 282T16076). Mioflazine suppresses nucleoside uptake. Mioflazine is an orally active nucleoside transport inhibitor. It has the potential for sleep disorders treatment.
Sizes: 5 mg, 25 mg, 100 mg, 50 mg, 1 mL * 10 mM (in DMSO)
From: €329.00
MIR96-IN-1 (Legacy Tebubio ref. 282T16077). MIR96-IN-1 selectively inhibits biogenesis of microRNA-96, upregulating a protein target (FOXO1) and inducing apoptosis in cancer cells.
Mirk-IN-1 (Legacy Tebubio ref. 282T16078). Mirk-IN-1 is an effective inhibitor of Dyrk1B(Mirk kianse) and Dyrk1A (IC50: 68±48 nM and 22±8 nM respectively).
